Approval · Notice of Compliance 17542 · 2015
CORTROSYN: Notice of Compliance 17542
Issued December 4, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17542
- Date
- December 4, 2015
- Company
- Amphastar Pharmaceuticals IncRancho Cucamonga, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing facility and revisions to the product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CORTROSYN | Not yet assigned | — |
Medicinal ingredients
- COSYNTROPIN 0.25 MG per VIAL